These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 36794365)
1. Development and validation of an [ Takahashi N; Tanaka S; Umezawa R; Takanami K; Takeda K; Yamamoto T; Suzuki Y; Katsuta Y; Kadoya N; Jingu K Acta Oncol; 2023 Feb; 62(2):159-165. PubMed ID: 36794365 [TBL] [Abstract][Full Text] [Related]
2. Combining the radiomic features and traditional parameters of Chen YH; Lue KH; Chu SC; Chang BS; Wang LY; Liu DW; Liu SH; Chao YK; Chan SC Ann Nucl Med; 2019 Sep; 33(9):657-670. PubMed ID: 31218571 [TBL] [Abstract][Full Text] [Related]
3. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer. Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507 [TBL] [Abstract][Full Text] [Related]
4. Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy. Yap WK; Chang YC; Hsieh CH; Chao YK; Chen CC; Shih MC; Hung TM Eur J Nucl Med Mol Imaging; 2018 May; 45(5):689-698. PubMed ID: 29188300 [TBL] [Abstract][Full Text] [Related]
5. Model integrating CT-based radiomics and genomics for survival prediction in esophageal cancer patients receiving definitive chemoradiotherapy. Cui J; Li L; Liu N; Hou W; Dong Y; Yang F; Zhu S; Li J; Yuan S Biomark Res; 2023 Apr; 11(1):44. PubMed ID: 37095586 [TBL] [Abstract][Full Text] [Related]
6. Lee S; Choi Y; Park G; Jo S; Lee SS; Park J; Shim HK Technol Cancer Res Treat; 2021; 20():15330338211024655. PubMed ID: 34227434 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of Song Y; Tian Y; Lu X; Chen G; Lv X Med Phys; 2024 Jul; 51(7):4907-4921. PubMed ID: 38252704 [TBL] [Abstract][Full Text] [Related]
8. Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer. Luo HS; Chen YY; Huang WZ; Wu SX; Huang SF; Xu HY; Xue RL; Du ZS; Li XY; Lin LX; Huang HC Radiat Oncol; 2021 Oct; 16(1):201. PubMed ID: 34641928 [TBL] [Abstract][Full Text] [Related]
9. Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT. Brown PJ; Zhong J; Frood R; Currie S; Gilbert A; Appelt AL; Sebag-Montefiore D; Scarsbrook A Eur J Nucl Med Mol Imaging; 2019 Dec; 46(13):2790-2799. PubMed ID: 31482428 [TBL] [Abstract][Full Text] [Related]
10. A nomogram based on pretreatment radiomics and dosiomics features for predicting overall survival associated with esophageal squamous cell cancer. Kawahara D; Nishioka R; Murakami Y; Emoto Y; Iwashita K; Sasaki R Eur J Surg Oncol; 2024 Jul; 50(7):108450. PubMed ID: 38843660 [TBL] [Abstract][Full Text] [Related]
11. Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer. Yap WK; Chang YC; Tseng CK; Hsieh CH; Chao YK; Su PJ; Hou MM; Yang CK; Pai PC; Lin CR; Hsieh CE; Wu YY; Hung TM Dis Esophagus; 2017 Aug; 30(8):1-10. PubMed ID: 28575243 [TBL] [Abstract][Full Text] [Related]
12. CT radiomics features of meso-esophageal fat in predicting overall survival of patients with locally advanced esophageal squamous cell carcinoma treated by definitive chemoradiotherapy. Yan S; Li FP; Jian L; Zhu HT; Zhao B; Li XT; Shi YJ; Sun YS BMC Cancer; 2023 May; 23(1):477. PubMed ID: 37231388 [TBL] [Abstract][Full Text] [Related]
13. 3'-deoxy-3'-[¹⁸F]-fluorothymidine PET/CT in early determination of prognosis in patients with esophageal squamous cell cancer: comparison with [¹⁸F]-FDG PET/CT. Chen H; Li Y; Wu H; Sun L; Lin Q; Zhao L; An H Strahlenther Onkol; 2015 Feb; 191(2):141-52. PubMed ID: 25163419 [TBL] [Abstract][Full Text] [Related]
14. Pretreatment CT and Rishi A; Zhang GG; Yuan Z; Sim AJ; Song EY; Moros EG; Tomaszewski MR; Latifi K; Pimiento JM; Fontaine JP; Mehta R; Harrison LB; Hoffe SE; Frakes JM J Med Imaging Radiat Oncol; 2021 Feb; 65(1):102-111. PubMed ID: 33258556 [TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted MRI and Xu X; Sun ZY; Wu HW; Zhang CP; Hu B; Rong L; Chen HY; Xie HY; Wang YM; Lin HP; Bai YR; Ye Q; Ma XM Radiat Oncol; 2021 Jul; 16(1):132. PubMed ID: 34281566 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of fibroblast activation protein expressing tumor volume calculated from [ Zhao L; Pang Y; Chen S; Chen J; Li Y; Yu Y; Huang C; Sun L; Wu H; Chen H; Lin Q Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):593-601. PubMed ID: 36222855 [TBL] [Abstract][Full Text] [Related]
17. Xu X; Sun X; Ma L; Zhang H; Ji W; Xia X; Lan X Front Oncol; 2023; 13():1149791. PubMed ID: 36969043 [TBL] [Abstract][Full Text] [Related]
18. Texture analysis of Nakajo M; Jinguji M; Nakabeppu Y; Nakajo M; Higashi R; Fukukura Y; Sasaki K; Uchikado Y; Natsugoe S; Yoshiura T Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):206-214. PubMed ID: 27613542 [TBL] [Abstract][Full Text] [Related]
19. A FDG-PET radiomics signature detects esophageal squamous cell carcinoma patients who do not benefit from chemoradiation. Li Y; Beck M; Päßler T; Lili C; Hua W; Mai HD; Amthauer H; Biebl M; Thuss-Patience PC; Berger J; Stromberger C; Tinhofer I; Kruppa J; Budach V; Hofheinz F; Lin Q; Zschaeck S Sci Rep; 2020 Oct; 10(1):17671. PubMed ID: 33077841 [TBL] [Abstract][Full Text] [Related]
20. Metabolic parameters of sequential 18F-FDG PET/CT predict overall survival of esophageal cancer patients treated with (chemo-) radiation. Li Y; Zschaeck S; Lin Q; Chen S; Chen L; Wu H Radiat Oncol; 2019 Feb; 14(1):35. PubMed ID: 30782182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]